CNR1 and obesity due to melanocortin 4 receptor deficiency: Taking into consideration the undeniable role of CB1R in the development of obesity and the role of CB1R agonists in obesity treatment, it is essential to further develop the research on CB1R-active substances, which have great potential in the treatment of obesity and obesity-related comorbidities.